vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Spok Holdings, Inc (SPOK). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $33.9M, roughly 1.1× Spok Holdings, Inc). Spok Holdings, Inc runs the higher net margin — 8.7% vs -161.8%, a 170.5% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -0.1%). Spok Holdings, Inc produced more free cash flow last quarter ($10.1M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Spok Holdings, Inc. is a global provider of critical communication solutions primarily serving the healthcare industry. It offers unified clinical communication platforms, secure messaging tools, alerting systems, and on-call scheduling software that help care teams coordinate efficiently, cut response times, and boost patient safety across medical facilities.
IBRX vs SPOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $33.9M |
| Net Profit | $-61.9M | $2.9M |
| Gross Margin | 99.0% | 76.7% |
| Operating Margin | -169.0% | 11.6% |
| Net Margin | -161.8% | 8.7% |
| Revenue YoY | 407.0% | -0.1% |
| Net Profit YoY | -4.7% | -19.6% |
| EPS (diluted) | $-0.06 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $33.9M | ||
| Q3 25 | $32.1M | $33.9M | ||
| Q2 25 | $26.4M | $35.7M | ||
| Q1 25 | $16.5M | $36.3M | ||
| Q4 24 | $7.6M | $33.9M | ||
| Q3 24 | $6.1M | $34.9M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $34.9M |
| Q4 25 | $-61.9M | $2.9M | ||
| Q3 25 | $-67.3M | $3.2M | ||
| Q2 25 | $-92.6M | $4.6M | ||
| Q1 25 | $-129.6M | $5.2M | ||
| Q4 24 | $-59.2M | $3.6M | ||
| Q3 24 | $-85.7M | $3.7M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $4.2M |
| Q4 25 | 99.0% | 76.7% | ||
| Q3 25 | 99.4% | 78.3% | ||
| Q2 25 | 99.5% | 79.5% | ||
| Q1 25 | 99.6% | 80.1% | ||
| Q4 24 | — | 78.5% | ||
| Q3 24 | — | 79.5% | ||
| Q2 24 | — | 78.9% | ||
| Q1 24 | — | 79.5% |
| Q4 25 | -169.0% | 11.6% | ||
| Q3 25 | -173.5% | 12.9% | ||
| Q2 25 | -269.8% | 15.1% | ||
| Q1 25 | -390.1% | 16.6% | ||
| Q4 24 | -919.0% | 13.7% | ||
| Q3 24 | -1314.3% | 14.2% | ||
| Q2 24 | — | 13.2% | ||
| Q1 24 | — | 14.0% |
| Q4 25 | -161.8% | 8.7% | ||
| Q3 25 | -209.8% | 9.5% | ||
| Q2 25 | -350.3% | 12.8% | ||
| Q1 25 | -784.9% | 14.3% | ||
| Q4 24 | -783.4% | 10.8% | ||
| Q3 24 | -1404.0% | 10.5% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 12.1% |
| Q4 25 | $-0.06 | $0.13 | ||
| Q3 25 | $-0.07 | $0.15 | ||
| Q2 25 | $-0.10 | $0.22 | ||
| Q1 25 | $-0.15 | $0.25 | ||
| Q4 24 | $-0.08 | $0.17 | ||
| Q3 24 | $-0.14 | $0.18 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $25.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $146.4M |
| Total Assets | $501.9M | $206.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $25.3M | ||
| Q3 25 | $257.8M | $21.4M | ||
| Q2 25 | $153.7M | $20.2M | ||
| Q1 25 | $61.6M | $19.9M | ||
| Q4 24 | $149.8M | $29.1M | ||
| Q3 24 | $130.4M | $27.8M | ||
| Q2 24 | — | $23.9M | ||
| Q1 24 | — | $23.3M |
| Q4 25 | $-500.5M | $146.4M | ||
| Q3 25 | $-524.3M | $148.7M | ||
| Q2 25 | $-570.7M | $150.9M | ||
| Q1 25 | $-591.4M | $151.7M | ||
| Q4 24 | $-489.1M | $154.7M | ||
| Q3 24 | $-745.1M | $156.3M | ||
| Q2 24 | — | $158.2M | ||
| Q1 24 | — | $160.2M |
| Q4 25 | $501.9M | $206.1M | ||
| Q3 25 | $519.0M | $209.7M | ||
| Q2 25 | $402.1M | $208.7M | ||
| Q1 25 | $303.8M | $204.5M | ||
| Q4 24 | $382.9M | $217.1M | ||
| Q3 24 | $364.6M | $216.8M | ||
| Q2 24 | — | $216.4M | ||
| Q1 24 | — | $215.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $11.5M |
| Free Cash FlowOCF − Capex | $-71.3M | $10.1M |
| FCF MarginFCF / Revenue | -186.2% | 29.9% |
| Capex IntensityCapex / Revenue | 2.4% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 3.93× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $25.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $11.5M | ||
| Q3 25 | $-68.9M | $8.1M | ||
| Q2 25 | $-79.7M | $7.0M | ||
| Q1 25 | $-85.9M | $2.3M | ||
| Q4 24 | $-85.1M | $8.4M | ||
| Q3 24 | $-98.8M | $11.1M | ||
| Q2 24 | — | $7.4M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | $-71.3M | $10.1M | ||
| Q3 25 | $-69.6M | $7.6M | ||
| Q2 25 | $-80.8M | $6.0M | ||
| Q1 25 | $-87.0M | $1.5M | ||
| Q4 24 | $-87.3M | $7.5M | ||
| Q3 24 | $-101.6M | $10.3M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | -186.2% | 29.9% | ||
| Q3 25 | -217.2% | 22.4% | ||
| Q2 25 | -305.9% | 16.8% | ||
| Q1 25 | -526.9% | 4.2% | ||
| Q4 24 | -1155.4% | 22.3% | ||
| Q3 24 | -1663.2% | 29.4% | ||
| Q2 24 | — | 20.0% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | 2.4% | 4.1% | ||
| Q3 25 | 2.3% | 1.6% | ||
| Q2 25 | 4.1% | 2.9% | ||
| Q1 25 | 6.8% | 2.1% | ||
| Q4 24 | 28.0% | 2.5% | ||
| Q3 24 | 45.7% | 2.4% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 2.5% |
| Q4 25 | — | 3.93× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 1.55× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | — | 3.03× | ||
| Q2 24 | — | 2.17× | ||
| Q1 24 | — | 0.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBRX
Segment breakdown not available.
SPOK
| Paging | $16.8M | 50% |
| Software Operations | $16.0M | 47% |
| License | $1.2M | 4% |
